The Federation of Experimental Biology Societies (FeSBE) held its 38th Annual Meeting from July 2 to 5, 2024, on the campus of the University of Campinas (Unicamp). Principal and associate researchers from CEPID CancerThera participated in the program as speakers in roundtables, symposia, and conferences.

FeSBE brings together 24 federated societies in the fields of biomedical research and experimental biology, totaling around 10,000 scientists across all Brazilian states. The meetings feature a comprehensive program that includes topics that cut across all areas of science, as well as specific topics of the federated societies, allowing the creation of networks that encourage collaborations between colleagues from different fields.

Below, we highlight the sessions attended by our center’s researchers and photos from their respective presentations.

July 3 – 10:30 a.m. to 12:30 p.m. > Roundtable: Expanding research centers in nuclear sciences in Brazilian research institutes and universities

Dr. Fabio Luiz Navarro Marques (Faculty of Medicine, University of São Paulo – FMUSP), associate researcher at CancerThera | Lecture 1: Three decades of transformation in the radiopharmacy research laboratory at the Nuclear Medicine Center – HC-FMUSP
Dr. Elvis Joacir de França (Northeast Regional Center for Nuclear Sciences – CRCN/NE) | Lecture 2: The role of CRCN in the development of research on radioisotopes in the Northeast region
Prof. Dr. Carmino Antônio de Souza (Unicamp), principal investigator and director of CancerThera | Lecture 3: The role of funding agencies and multidisciplinarity in creating a research center for radiochemistry and radiopharmacy at Unicamp
Dr. Camila Salata (National Nuclear Energy Commission – CNEN) | Lecture 4: The role of CNEN in licensing and supporting new research laboratories

July 3 – 2:00 p.m. to 4:00 p.m. > Symposium: New radiolabeled molecules as theranostics for cancer

Prof. Dr. Luciana Malavolta Quaglio (Faculty of Medical Sciences of Santa Casa de São Paulo – FCMSCSP), principal researcher at CancerThera | Lecture 1: Radiolabeled peptides that interact with overexpressed receptors in tumors. Potential theranostic molecules?
Prof. Dr. Leonardo Lima Fuscaldi (FCMSCSP), associate researcher at CancerThera | Lecture 2: The use of theranostic molecules in molecular imaging and treatment of tumorous diseases
Dr. Aryel Heitor Ferreira (MackGraphe) | Lecture 3: Design of Nanomaterials for Theranostics – Customizing Properties according to the pathology
Prof. Dr. Celso Dario Ramos (Unicamp), principal investigator and deputy director of CancerThera | Lecture 4: Clinical applications of theranostic radiopharmaceuticals in oncology

July 3 – 4:00 p.m. to 5:00 p.m. > Conference: Coordination Chemistry and the Theranostic Approach in Nuclear Medicine

Prof. Dr. Victor Marcelo Deflon (Institute of Chemistry of São Carlos, University of São Paulo – IQSCUSP), principal researcher at CancerThera

July 4 – 9:00 a.m. to 10:00 a.m. > Course: From the conception of a radiopharmaceutical to clinical translation

Dr. Fabio Luiz Navarro Marques (FMUSP), associate researcher at CancerThera | Lecture 2: A new radiopharmaceutical: molecular targets and experimental design

July 5 – 4:00 p.m. to 5:00 p.m. > Conference: Metabolic alterations in cancer